跳至主要内容
临床试验/NCT06624969
NCT06624969尚未招募不适用

Virtual Reality in Reducing Acute Orthopedic Pain

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
Mayo Clinic
入组人数
100
试验地点
1
主要终点
opioid use

研究概览

简要总结

The primary aim of this research is to show that a virtual reality (VR) service line is feasible and can sustain itself with the ability to take care of patients. Additionally, the investigators aim to learn about the limitations of a service line and provide a pathway for future improvements in building a VR service line that is optimally aligned with the user's needs. Secondary aims are to evaluate the clinical aspects of the patient's outcomes including length of stay, morphine equivalents in pain medicine required during the hospital stay, and user experiences.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospitalized with an orthopedic fracture
  • Able to participate fully in all aspects of the study
  • Able to understand and sign informed consent
  • Individuals with unaided vision or those who can correct their vision using contact lenses

排除标准

  • Non-English speaking
  • Self-reported history of acute and/or chronic severe motion sickness
  • The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted display.
  • Legally blind or deaf
  • Have had a seizure within the past 1 year
  • Have current (within the past 30 days) clinically significant acute or chronic progressive or unstable/uncontrolled neurologic disorder
  • Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence

研究组 & 干预措施

Virtual reality

Experimental

Intervention with virtual reality

干预措施: virtual reality (Other)

Standard of care

No Intervention

No virtual reality intervention

结局指标

主要结局

opioid use

时间窗: From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks

Change in opioid equivalents during hospital stay from hospital admission to discharge

次要结局

  • reduction in anxiolytics(From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks)
  • hospital length of stay(From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks)
  • reduction in sleep aids prescribed(From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks)
  • User experiences(obtained once on the day of hospital discharge, up to 5 weeks from study enrollment)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott A. Helgeson

Consultant, Assistant Professor of Medicine

Mayo Clinic

研究点 (1)

Loading locations...

相似试验